CervoMed Inc.

NASDAQ: CRVO
Share price (10/20/25): $7.51
Market cap (10/20/25): $69.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Shelf registration

Ownership Filter

Ra Capital Management, L.P.

Ra Capital Management, L.P.

News Filter

Announces New Data From Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia With Lewy Bodies

Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Material Disclosure, Financial Statements or Exhibits

At Week 32 of the Extension Phase, Patients Treated With Neflamapimod Demonstrated a Significant Reduction From Baseline in Plasma Levels of Glial Fibrillary Acidic Protein

Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Revised preliminary proxy by non-management

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC